Find a Tender
complete
Official procurement procedure
Blood Glucose Meters & Associated Consumables
Blood-testing reagents
Published value
Not published
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust): "Blood Glucose Meters & Associated Consumables". Published status: complete. Published value: Value not published. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
| Contracting Authority | NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) | Scope & Categories | Not published | Submission Window | complete No deadline published |
|---|---|---|---|---|---|
| Submission Gateway | Direct notice route | Legal Basis & Regime | Standard procurement | Estimated Value (exc. VAT) | Not published |
Bidder Intelligence · Authority Profile: NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)
Market Analytics
Derived from OCDS awards & bid statistics
Published history for NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust). These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Competition Density
1.9Bids / Report
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate availablePayment Terms
Check noticePublished terms
Coverage: 443 active published awards; 365 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Procedure methodNot published | Procurement categoryNot published | |
Statuscomplete | Framework / DPSNot published | CompetitionNot published |
Above thresholdNot published | Legal basisNot published | Tender period startsNot published |
Clarification deadlineNot published | Electronic submissionNot published | Submission languagesNot published |
Published21 Oct 2021, 17:04 BST | Last source update21 Oct 2021, 17:04 BST | Recurring procurementNot published |
ClassificationBlood-testing reagents | ||
Delivery area | ||
OCIDocds-h6vhtk-02eebd | ||
What is being bought
Supply of Blood testing equipment (Glucose Meters) & associated consumables (Test-strips). together with EQA & IQA
What changed
From the official release history
- Status changed to complete
21 Oct 2021, 17:04 BST - Official notice release published
21 Oct 2021, 17:04 BST - Buyer information updated
21 Oct 2021, 17:04 BST
Lots and requirements (1)
Published by the contracting authority
- Lot 1 · #1Individual lot title not publishedStatus not publishedPublished valueNot publishedBlood glucose monitoring refers to testing the concentration of glucose in the blood to aid the management of Diabetes types 1 & 2. Similarly, monitoring the presence of ketones in the blood is also important as high levels can result in complications such as Ketoacidosis. This procurement will involve the supply of Blood glucose monitoring equipment(meters) and associated consumables (Test-strips for the Point of Care Testing Service at Swansea Bay University Health Board & Princess of Wales Hospital, Bridgend. This will be to renew the existing arrangement with Abbott Laboratories Ltd.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
Timeline
- Procedure published
21 Oct 2021, 17:04 BST - Award active
Not published · Not published - Contract active
Signed 5 Oct 2021, 00:00 BST · £468,765
Commercial outcome and competition
Awards Abbott Laboratories Ltd Not published · Not published · active |
Contracts Contract £468,765 · signed 5 Oct 2021, 00:00 BST · active |
Bid statisticsNo aggregate bid statistics published |
Buyer and organisations in this procedure
NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)
Contracting authority GB-FTS-109Documents (0)
Official links; attachments are not copied
No linked documents are published
Related procedures (0)
No related procedures published
Planning and rationale
Planning budgetNot published |
No-engagement rationaleNot published |
Procedure rationaleThe current contract with Abbott Laboratories Ltd ended on the 30th September 2021. The Health Board's intention was to enter into a 2 year contract with Abbott Laboratories Ltd through a direct award under the terms of a Public Sector Framework. This would enable sufficient time for NWSSP Shared Services Procurement to undertake a formal market-test exercise, to award a new All Wales Framework in Autumn 2023. Currently, the Health Board's POCT Service are not able to contemplate an alternative supplier for the reasons outlined below:
Within SBU there are 3,279 active operators and the SBU POCT Team also support another 937 on the Princess of Wales (PoW) site under the terms of an SLA
The migration of operators to a completely new device would need to be completed on a rolling basis with full training for every member of staff. The POCT Team is not in a position to support this due to the extra training demands in relation to Covid-19 and the clinical areas are still finding it difficult to release staff to attend training, due to staffing pressures.
The current management of testing allows for staff to move flexibly from one area or site to another. During the process of migration this flexibility will be lost to a degree with some areas using the new meter and other areas using the existing meter, this could expose the HB to risk, given current staffing pressures.
Unfortunately, the Health Board cannot find a Public Sector Framework with which to engage with Abbott Laboratories Ltd at this time and therefore, there is no opportunity to make a compliant direct award.
For the reasons outlined above and to ensure continuity of service for patient care, the Health Board has no option but to extend for two years without any formal underpinning Framework arrangement.
In the interim the Health Board is committed to the All Wales market test which will come to fruition in Autumn 2023, for a new formal contract for Point of Care Blood Glucose & Ketone Testing. |